The trial, sponsored by Bioaraba Health Research Institute, aims to evaluate a triple intervention strategy for glycemic control in prediabetic patients, a growing segment due to rising diabetes prevalence. The market for diabetes management is substantial, with increasing demand for non-pharmacological interventions. If successful, this trial could position Bioaraba as a leader in preventive diabetes care, potentially leading to partnerships with healthcare providers and payers focused on cost-effective management strategies. Competitive landscape includes other lifestyle intervention studies, but the specific combination of apple cider vinegar and structured meal sequencing may offer a unique selling proposition.